#66 Hepatitis C: Workup and Treatment in Primary Care
Nov 06, 2017, 08:00 AM
Hiding from Hep C? Dive in with experts Dr. Gina Simoncini, MD, MPH Associate Professor of Clinical Medicine at Temple University Hospital, & Dr. David Koren, PharmD, BCPS, AAHIVP, board-certified pharmacotherapy specialist and infectious diseases clinical pharmacist at Temple University Hospital. They walk us through a simplified approach on whom to screen, how to start antiviral therapy, what to follow up on, and how to navigate insurance waters along the way. Special thanks to Sarah Roberts and Jordana Kozupsky who wrote and produced this episode and the show notes!
Full show notes available at http://thecurbsiders.com/podcast
Join our mailing list and receive a PDF copy of our show notes every Monday. Rate us on iTunes, recommend a guest or topic and give feedback at thecurbsiders@gmail.com.
Time Stamps
- 00:00 Intro
- 01:00 Guest bios
- 03:00 Getting to know our guests
- 05:35 Picks of the week
- 10:05 Clinical case
- 10:54 Diagnosing HCV
- 12:00 ASCEND study
- 13:14 Restrictions on HCV treatment
- 15:17 Ordering and interpreting pre-treatment tests
- 19:30 Prescribing medication
- 22:00 Genotyping and drug resistance
- 24:10 Patient counseling
- 25:49 Understanding drug classes
- 27:33 Drug interactions
- 30:06 Multidisciplinary approach to treatment
- 33:01 Follow-up
- 36:47 Reinfection/cure rates
- 39:35 Patient counseling revisited
- 41:25 Side effects of treatment
- 42:53 Screening
- 44:02 Take home points
Tags: hepatitis, virus, hcv, direct-acting, antiviral, therapy, management, primary, care, liver, ultrasound, fibrosis, cirrhosis, side, effects, monitoring, hcc, hiv, infectious, disease, assistant, education, doctor, family, foam, foamed, health, hospitalist, hospital, internal, internist, nurse, meded, medicine,